Cholesterol, VLDL
Research News and Information

Monday, November 23, 2009

Regular feeding plays an important role in cholesterol homeostasis through the liver circadian clock.

4 Aug 2009 RATIONALE: Peripheral clock control and the relevance of the circadian rhythm to physiology and disease are major questions in mammalian circadian biology. OBJECTIVE: We examined the physiological functions of the liver clock. METHODS AND RESULTS: ... Read more...

Decreased serum lipids in patients with probable Alzheimer's disease.

30 Jul 2009 Alzheimer;s disease (AD) is a multifactorial disease but its aetiology and pathophisiology are still not fully understood. Epidemiologic studies examining the association between lipids and dementia have reported conflicting results. High total ... Read more...

Control of ACAT2 liver expression by HNF4{alpha}: lesson from MODY1 patients.

26 May 2009 OBJECTIVE: ACAT2 is thought to be responsible for cholesteryl ester production in chylomicron and VLDL assembly. Recently, we identified HNF1alpha as an important regulator of the human ACAT2 promoter. Thus, we hypothesized that MODY3 (HNF1alpha ... Read more...

Latest indexed articles for 'Cholesterol, VLDL'

These are the very latest articles for this heading:

• Regular feeding plays an important role in cholesterol homeostasis through the liver circadian clock. 4 Aug 2009
• Decreased serum lipids in patients with probable Alzheimer's disease. 30 Jul 2009
• Control of ACAT2 liver expression by HNF4{alpha}: lesson from MODY1 patients. 26 May 2009
• [Diabetic dyslipoproteinemia: beyond LDL] 4 May 2009
• Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study). 2 May 2009
• Changes in serum homocysteine level follow two different trends in patients during early post myocardial infarction period. 29 Apr 2009
• Cholesteryl ester transfer protein (CETP) increases postprandial triglyceridaemia and delays triacylglycerol plasma clearance in transgenic mice. 29 Apr 2009
• A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol in metabolic syndrome patients. 27 Apr 2009
• Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats. 6 Apr 2009
• Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity. 30 Mar 2009
• Serum lipid concentrations in dogs with tail chasing. 27 Feb 2009
• Do serum lipids predict response to clozapine treatment? 27 Feb 2009
• Fasted to fed trafficking of Fatty acids in human adipose tissue reveals a novel regulatory step for enhanced fat storage. 15 Feb 2009
• The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice. 11 Feb 2009
• Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis. 3 Feb 2009
• Effect of Piper betle on plasma antioxidant status and lipid profile against D-galactosamine-induced hepatitis in rats. 30 Dec 2008
• Human plasma phospholipid transfer protein specific activity is correlated with HDL size: implications for lipoprotein physiology. 28 Dec 2008
• Effects of various dietary arginine and lysine concentrations on plasma and liver cholesterol concentrations in rats. 9 Dec 2008
• Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice. 4 Dec 2008
• Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice. 29 Nov 2008

See a longer list of these articles.

Technical information about 'Cholesterol, VLDL'

Definition: Cholesterol which is contained in or bound to very low density lipoproteins (VLDL). High circulating levels of VLDL cholesterol are found in HYPERLIPOPROTEINEMIA TYPE IIB. The cholesterol on the VLDL is eventually delivered by LOW-DENSITY LIPOPROTEINS to the tissues after the catabolism of VLDL to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LDL.

Registry Number: 0

Descriptor UI: D015243

Alternative terms: Cholesterol, VLDL; Prebetalipoprotein Cholesterol; Cholesterol, Prebetalipoprotein; VLDL Cholesterol; Pre-beta-Lipoprotein Cholesterol; Cholesterol, Pre-beta-Lipoprotein; Pre beta Lipoprotein Cholesterol; Very Low Density Lipoprotein Cholesterol;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D10.532.599.700; D10.570.938.208.285; D12.776.521.622.700;

History Note: 2007 (1989)